New Philips Sonicare ProtectiveClean Power Toothbrush Awarded ADA Seal of Acceptance

STAMFORD, United States The American Dental Association (ADA) has awarded its ADA Seal of Acceptance to Philips Sonicare ProtectiveClean 4100 Plaque Control, an innovation from the power toothbrush brand most often recommended by U.S. Dental Professionals.
The ADA Council on Scientific Affairs’ acceptance of Philips Sonicare ProtectiveClean 4100 Plaque Control is based on its finding that the power toothbrush is safe and has shown efficacy in removing plaque and helping to prevent and reduce gingivitis, when used as directed.
To earn the Seal of Acceptance, the manufacturer, Philips Personal Health, was subjected to ADA laboratory tests and had to meet ADA and American National Standards Institute- approved dental standards. The company also submitted studies proving clinical safety and efficacy. Philips Sonicare Protective Clean 4100 Plaque Control Toothbrush was submitted for consideration as it is a contemporary innovation within the Sonicare portfolio.
The ADA’s validation demonstrates the level of care that Philips Sonicare power toothbrushes provide,” said Alexander Harris, Senior Marketing Director, Philips Oral Healthcare. We feel that the ADA Seal formalizes the relationship between the two clinically- dedicated oral healthcare organizations and are we proud to have received this honor.
A gentle and effective clean
The Philips Sonicare ProtectiveClean 4100 power toothbrush is designed to address consumer concerns that they are brushing too hard with their existing toothbrush and could be damaging their teeth and gums in the process. Featuring unique pressure sensor technology, Philips Sonicare ProtectiveClean alerts users when they are applying too much pressure, delivering a gentle brushing experience for healthier gums, cleaner teeth, and a whiter smile.
Philips Sonicare ProtectiveClean is proven to reduce gum disease by up to 100% and to remove up to seven times more plaque than a manual toothbrush[1] for improved oral health.
[1] When used in clean mode with the Optimal Plaque Control brush head – Philips data on file 2017
The toothbrush uses unique technology and a sonic sweeping motion to create gentle microbubbles for an exceptional clean feeling.
Please visit for more information about Philips Sonicare and Philips Sonicare ProtectiveClean.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image- guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at
Continue reading

OraCoat® XyliMelts® Combat Tooth Erosion by Reducing Gastroesophageal Reflux Disease (GERD)

A Recent Study Shows that Nightly Use of Oral Adhering Discs Significantly Improves Symptoms Associated with GERD
Seattle, WA (February 21, 2018) – An article about a recent clinical study, “Dental Erosion, GERD, and Salivary Stimulation,” published in the Journal of Oral & Dental Health, February 2018, reports that OraCoat® XyliMelts® oral adhering discs used while sleeping reduce reflux of stomach acids, in gastroesophageal reflux disease (GERD), which causes tooth erosion. In patients with GERD, the esophagus is exposed to stomach acid long enough to cause symptoms.
GERD is estimated to occur in ten to thirty percent of the population in developed countries and is known to contribute to or cause a number of medical and dental problems including heartburn (chest pain), sore throat, mucosal pathology, bruxism, and tooth erosion. The condition is also associated with sleep disturbance and can have a detrimental effect on nighttime comfort and overall quality of life. Saliva is believed to play an integral role in combatting symptoms of GERD by protecting the esophageal lining by way of diluting and neutralizing stomach acid that enters the esophagus through reflux. However, saliva production normally decreases at night and, when the body is prone, gravity no longer helps to keep the acid down.
The study was conducted as a randomized, double-blind, controlled trial involving two
over-the-counter products currently on the market for use in the management of dry mouth symptoms, one a sweet gel, and the other XyliMelts oral adhering discs that contain 550 mg of xylitol for sweetness to stimulate saliva flow, cellulose gum to slow dissolution and lubricate the mouth, a layer of acacia gum to adhere to gingiva or teeth, and a small amount of calcium carbonate to neutralize acidity. XyliMelts used at night while sleeping is the most effective per gram delivery of xylitol to maintain an adequate concentration of saliva in the mouth to reduce tooth decay.
Results of the study revealed that nightly use of both XyliMelts and the sweet gel remedies significantly reduced symptoms associated with GERD, including reflux acid taste, nighttime heartburn, morning hoarseness, and perceived reflux. Moreover, XyliMelts were found to be generally more effective in reducing GERD symptoms than the gel, and significantly more effective in improving heartburn. These study results carry important implications for dentists treating erosion associated with GERD, and offer a viable remedy for GERD sufferers to combine with dental restorative care and medical intervention to manage erosion and all the problems of acid reflux while sleeping.
No significant side effects were reported from any participants during product use.
XyliMelts are available over the counter at CVS, Rite Aid, and are coming to Walmart in
March 2018. For more information on XyliMelts, visit
A companion product to XyliMelts is XyliGel®, a soothing, sweet gel with 17% xylitol buffered to pH 7.4 to relieve dry mouth and neutralize acids in the mouth. It works especially well for people with very low levels of saliva. XyliGel is available online at
Documentation of all statements is available upon request. A PDF of this article is available at:
About OraCoat
OraCoat is the world leader in the breakthrough technology of “oral adhering discs” which slowly release ingredients in the mouth and are safe for use while sleeping. The OraCoat® brand represents a family of products that solve oral care problems by coating the mouth with safe ingredients that become effective when they are slowly released. OraCoat’s leading products are XyliMelts® and XyliGel OTC products for dry mouth. Other oral care solutions in the OraCoat family are planned. OraCoat’s innovative oral care solutions are backed by careful research based on medical science to ensure optimum performance and user safety.
Continue reading

Align Technology Rejects SmileDirectClub Claim That Invisalign Store Pilot Constitutes Breach of Non-Compete and Confidentiality Provisions

February 28, 2018 16:59 ET

SAN JOSE, CA–(Marketwired – February 28, 2018) – Align Technology, Inc. (NASDAQ: ALGN) today announced that it included the following disclosure in its Form 10-K for the year ended December 31, 2017. Align is currently evaluating the potential impact that this could have on our consolidated financial statements; however, Align does not anticipate this matter to impact its expected volumes and revenues from SmileDirectClub (SDC) for 2018.
In February 2018, we received a communication on behalf of SDC Financial LLC, SmileDirectClub LLC, and the Members of SDC Financial LLC other than Align (collectively, the "SDC Entities") alleging that the launch and operation of our Invisalign store pilot program constitutes a breach of non-compete provisions applicable to the members of SDC Financial LLC, including Align. As a result of this alleged breach, SDC Financial LLC has notified Align that its members (other than Align) seek to exercise a right to repurchase all of Align’s SDC Financial LLC membership interests for a purchase price equal to the current capital account balance of Align. The SDC Entities also allege that Align has breached confidentiality provisions applicable to the SDC Financial LLC members and demands that Align cease all activities related to the Invisalign store pilot project, close existing Invisalign stores and cease using SDC’s confidential information. Align disputes the allegations that it has breached its obligations to the SDC Entities, including the allegation that the SDC Entities are entitled to exercise a repurchase right. Pursuant to the parties’ agreement, the dispute will be arbitrated if it is not resolved through negotiations.
Commenting on today’s filing, Align Technology President and CEO Joe Hogan said, "We are surprised that SmileDirectClub (SDC) has asserted that the launch of our Invisalign pilot stores violates our non-compete or confidentiality agreements with SDC. The Invisalign pilot store is the evolution of years of Invisalign consumer marketing designed to connect interested consumers with Invisalign doctor-led offices for treatment. Align has consistently acted in good faith and will work to resolve these allegations as quickly as possible. This dispute does not impact Align’s existing supply agreement with SDC which remains in place through 2019 and includes a minimum volume commitment. We are currently evaluating the potential impact that this could have on our consolidated financial statements and we do not anticipate this matter to impact expected volumes and revenues from SDC for 2018. Align will continue to operate its Invisalign store pilot program, which includes a pilot store in San Francisco and a new pilot store that opened in San Jose, California last week."
Forward Looking Statement:This release may contain forward-looking statements based on Align Technology’s current expectations. These forward-looking statements involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, uncertainties involved in any contract dispute resolution and the possibility of Align choosing to settle the litigation for business or other reasons. These factors, as well as other factors that could cause actual results to differ materially, are discussed in more detail in Align Technology’s Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission on February 28, 2018, as well as in other reports and documents filed from time to time with the Securities and Exchange Commission.
About Align Technology, Inc.Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align’s products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit for more information.
For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit For additional information about iTero digital scanning system, please visit

Continue reading